![](/img/cover-not-exists.png)
Epirubicin dose and sequential hormonal therapy—Mature results of the HMFEC randomised phase III trial in premenopausal patients with node positive early breast cancer
Coombes, R.C., Kilburn, L.S., Tubiana-Mathieu, N., Olmos, T., Van Bochove, A., Perez-Lopez, F.R., Palmieri, C., Stebbing, J., Bliss, J.M.Volume:
60
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2016.03.001
Date:
June, 2016
File:
PDF, 512 KB
english, 2016